Early detection of age related macular degeneration: current status

Early diagnosis and treatment of choroidal neovascularization (CNV), a main cause of severe vision loss in age related macular degeneration (AMD), is crucial in order to preserve vision and the quality of life of patients. This review summarizes current literature on the subject of early detection o...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartz, Roy, Loewenstein, Anat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088451/
https://www.ncbi.nlm.nih.gov/pubmed/27847613
http://dx.doi.org/10.1186/s40942-015-0022-7
_version_ 1782464098533900288
author Schwartz, Roy
Loewenstein, Anat
author_facet Schwartz, Roy
Loewenstein, Anat
author_sort Schwartz, Roy
collection PubMed
description Early diagnosis and treatment of choroidal neovascularization (CNV), a main cause of severe vision loss in age related macular degeneration (AMD), is crucial in order to preserve vision and the quality of life of patients. This review summarizes current literature on the subject of early detection of CNV, both in the clinic setting and mainly in the patient’s home. New technologies are evolving to allow for earlier detection and thus vision preservation in AMD patients.
format Online
Article
Text
id pubmed-5088451
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50884512016-11-15 Early detection of age related macular degeneration: current status Schwartz, Roy Loewenstein, Anat Int J Retina Vitreous Review Early diagnosis and treatment of choroidal neovascularization (CNV), a main cause of severe vision loss in age related macular degeneration (AMD), is crucial in order to preserve vision and the quality of life of patients. This review summarizes current literature on the subject of early detection of CNV, both in the clinic setting and mainly in the patient’s home. New technologies are evolving to allow for earlier detection and thus vision preservation in AMD patients. BioMed Central 2015-12-01 /pmc/articles/PMC5088451/ /pubmed/27847613 http://dx.doi.org/10.1186/s40942-015-0022-7 Text en © Schwartz and Loewenstein. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Schwartz, Roy
Loewenstein, Anat
Early detection of age related macular degeneration: current status
title Early detection of age related macular degeneration: current status
title_full Early detection of age related macular degeneration: current status
title_fullStr Early detection of age related macular degeneration: current status
title_full_unstemmed Early detection of age related macular degeneration: current status
title_short Early detection of age related macular degeneration: current status
title_sort early detection of age related macular degeneration: current status
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088451/
https://www.ncbi.nlm.nih.gov/pubmed/27847613
http://dx.doi.org/10.1186/s40942-015-0022-7
work_keys_str_mv AT schwartzroy earlydetectionofagerelatedmaculardegenerationcurrentstatus
AT loewensteinanat earlydetectionofagerelatedmaculardegenerationcurrentstatus

Ejemplares similares